Non-alcoholic fatty liver disease: a massive problem

doi:10.7861/clinmedicine.11-2-176

Review

. 2011 Apr;11(2):176-8.

doi: 10.7861/clinmedicine.11-2-176.

Non-alcoholic fatty liver disease: a massive problem

Christopher P Day¹

Affiliations

PMID: 21526706
PMCID: PMC5922746
DOI: 10.7861/clinmedicine.11-2-176

Review

Non-alcoholic fatty liver disease: a massive problem

Christopher P Day. Clin Med (Lond). 2011 Apr.

. 2011 Apr;11(2):176-8.

doi: 10.7861/clinmedicine.11-2-176.

Author

Christopher P Day¹

Affiliation

¹ Institute of Cellular Medicine, Faculty of Medical Sciences, Newcastle University. c.p.day@ncl.ac.uk

PMID: 21526706
PMCID: PMC5922746
DOI: 10.7861/clinmedicine.11-2-176

No abstract available

PubMed Disclaimer

Cited by

Unveiling Resmetirom: A systematic review and meta-analysis on its impact on liver function and safety in non-alcoholic steatohepatitis treatment.
Hashim HT, Alhatemi AQM, Riaz S, Al-Ghuraibawi MA, Alabide AS, Saeed H, Sulaiman FA, Alhussain MAA, Shallan MA, Al-Obaidi AD, Saab O, Al-Obaidi H, Hashim AT, Merza N. Hashim HT, et al. JGH Open. 2024 Oct 1;8(10):e70025. doi: 10.1002/jgh3.70025. eCollection 2024 Oct. JGH Open. 2024. PMID: 39359614 Free PMC article. Review.
Oral supplementation of gut microbial metabolite indole-3-acetate alleviates diet-induced steatosis and inflammation in mice.
Ding Y, Yanagi K, Yang F, Callaway E, Cheng C, Hensel ME, Menon R, Alaniz RC, Lee K, Jayaraman A. Ding Y, et al. Elife. 2024 Feb 27;12:RP87458. doi: 10.7554/eLife.87458. Elife. 2024. PMID: 38412016 Free PMC article.
Prevalence of fatty liver and its related factors in children.
Sadeghian M, Vafadar M, Torabi A, Torabi S, Fazel M. Sadeghian M, et al. J Family Med Prim Care. 2022 Sep;11(9):5604-5608. doi: 10.4103/jfmpc.jfmpc_626_22. Epub 2022 Oct 14. J Family Med Prim Care. 2022. PMID: 36505576 Free PMC article.
Ch25h and 25-HC prevent liver steatosis through regulation of cholesterol metabolism and inflammation.
Wang Y, Zhang J, Chen J, Wang D, Yu Y, Qiu P, Wang Q, Zhao W, Li Z, Lei T. Wang Y, et al. Acta Biochim Biophys Sin (Shanghai). 2022 Apr 25;54(4):504-513. doi: 10.3724/abbs.2022030. Acta Biochim Biophys Sin (Shanghai). 2022. PMID: 35462473 Free PMC article.
Factors That Predict the Progression of Non-alcoholic Fatty Liver Disease (NAFLD).
Parameswaran M, Hasan HA, Sadeque J, Jhaveri S, Avanthika C, Arisoyin AE, Dhanani MB, Rath SM. Parameswaran M, et al. Cureus. 2021 Dec 28;13(12):e20776. doi: 10.7759/cureus.20776. eCollection 2021 Dec. Cureus. 2021. PMID: 35111461 Free PMC article. Review.

See all "Cited by" articles

References

1. Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600–6. doi: 10.1016/j.jhep.2006.06.013. - DOI - PubMed
1. Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30:1212–8. doi: 10.2337/dc06-2247. - DOI - PubMed
1. Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009;51:371–9. doi: 10.1016/j.jhep.2009.03.019. - DOI - PubMed
1. Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis. C. Hepatology. 2006;43:682–9. doi: 10.1002/hep.21103. - DOI - PubMed
1. Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–73. doi: 10.1002/hep.21327. - DOI - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources

[1] Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600–6. doi: 10.1016/j.jhep.2006.06.013. - DOI - PubMed

[2] Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histology in obese patients undergoing bariatric surgery. J Hepatol. 2006;45:600–6. doi: 10.1016/j.jhep.2006.06.013. - DOI - PubMed

[3] Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30:1212–8. doi: 10.2337/dc06-2247. - DOI - PubMed

[4] Targher G, Bertolini L, Padovani R, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care. 2007;30:1212–8. doi: 10.2337/dc06-2247. - DOI - PubMed

[5] Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009;51:371–9. doi: 10.1016/j.jhep.2009.03.019. - DOI - PubMed

[6] Argo CK, Northup PG, Al-Osaimi AM, Caldwell SH. Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis. J Hepatol. 2009;51:371–9. doi: 10.1016/j.jhep.2009.03.019. - DOI - PubMed

[7] Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis. C. Hepatology. 2006;43:682–9. doi: 10.1002/hep.21103. - DOI - PubMed

[8] Sanyal AJ, Banas C, Sargeant C, et al. Similarities and differences in outcomes of cirrhosis due to nonalcoholic steatohepatitis and hepatitis. C. Hepatology. 2006;43:682–9. doi: 10.1002/hep.21103. - DOI - PubMed

[9] Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–73. doi: 10.1002/hep.21327. - DOI - PubMed

[10] Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology. 2006;44:865–73. doi: 10.1002/hep.21327. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Non-alcoholic fatty liver disease: a massive problem

Affiliation

Non-alcoholic fatty liver disease: a massive problem

Author

Affiliation

Similar articles

Cited by

References

Publication types

MeSH terms

Substances

LinkOut - more resources

Full Text Sources